President and CEO of the Central Indiana Corporate Partnership
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Director, Life Sciences Institute, University of Michigan
Vaccines have long been a neglected stepchild of the pharmaceutical industry, regarded by many as a high-risk, high-liability, low-profit backwater. Even the massive influx of world-class research and worldwide attention prompted by the search for an HIV vaccine failed to breathe life into the industry. So why do many venture capitalists and philanthropists consider now the best time in history to invest in vaccines? What has changed in biology that is paving the way for a new breed of immunizations? How big is the opportunity for business and human health?
Come hear from some of the world’s leading authorities on these questions at the inaugural Xconomy Forum here in Seattle. This panel discussion and networking event will bring together pioneers in research, development, and commercial implementation of the next generation of vaccines.
John Aitchison, ISB Associate Director
Todd Patrick – Former President, ID Biomedical (moderator)
Steve Reed – Founder, Infectious Disease Research Institute; CEO, Immune Design
Chris Elias – CEO, PATH
Denise Galloway – Professor of Microbiology, Fred Hutchinson Cancer Research Center
Registration begins at 6:00 pm.
The program begins at 6:30 pm.
A networking reception will follow the program.
Early Bird Registration (ends December 1): $75.00
Regular Registration: $95.00
Student Registration: $25.00
Tickets are transferable but not refundable.